Rafferty Asset Management’s Ginkgo Bioworks DNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,091
| Closed | -$468K | – | 1180 |
|
|
2024
Q1 | $468K | Sell |
10,091
-1,183
| -10% | -$54.9K | ﹤0.01% | 991 |
|
|
2023
Q4 | $762K | Buy |
11,274
+1,482
| +15% | +$100K | ﹤0.01% | 866 |
|
|
2023
Q3 | $709K | Sell |
9,792
-120
| -1% | -$8.69K | ﹤0.01% | 864 |
|
|
2023
Q2 | $737K | Buy |
9,912
+223
| +2% | +$16.6K | ﹤0.01% | 893 |
|
|
2023
Q1 | $515K | Sell |
9,689
-88
| -0.9% | -$4.68K | ﹤0.01% | 930 |
|
|
2022
Q4 | $661K | Buy |
9,777
+938
| +11% | +$63.4K | 0.01% | 848 |
|
|
2022
Q3 | $1.1M | Buy |
8,839
+8,298
| +1,534% | +$1.04M | 0.01% | 647 |
|
|
2022
Q2 | $52K | Buy |
+541
| New | +$52K | ﹤0.01% | 1100 |
|